Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 8.22 USD 1.48% Market Closed
Market Cap: 308m USD

Operating Margin

-1.8%
Current
Improving
by 9.8%
vs 3-y average of -11.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1.8%
=
Operating Income
$-2.4m
/
Revenue
$135.3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1.8%
=
Operating Income
$-2.4m
/
Revenue
$135.3m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Lifecore Biomedical Inc
NASDAQ:LFCR
308m USD
Loading...
JP
Goyo Foods Industry Co Ltd
TSE:2230
53.2T JPY
Loading...
CH
Nestle SA
SIX:NESN
190.3B CHF
Loading...
US
Mondelez International Inc
NASDAQ:MDLZ
73.9B USD
Loading...
FR
Danone SA
PAR:BN
48.5B EUR
Loading...
ZA
Tiger Brands Ltd
JSE:TBS
53.6B Zac
Loading...
MY
Ocb Bhd
KLSE:OCB
204B MYR
Loading...
US
Hershey Co
NYSE:HSY
40.1B USD
Loading...
CN
Muyuan Foods Co Ltd
SZSE:002714
258.6B CNY
Loading...
ZA
Avi Ltd
JSE:AVI
36.4B Zac
Loading...
CH
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
26.4B CHF
Loading...
No Stocks Found

Market Distribution

Lower than 75% of companies in the United States of America
Percentile
25th
Based on 11 913 companies
25th percentile
-1.8%
Low
-3 291 400% — 1.3%
Typical Range
1.3% — 16.8%
High
16.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -3 291 400%
30th Percentile 1.3%
Median 8.6%
70th Percentile 16.8%
Max 1 032 600%

Lifecore Biomedical Inc
Glance View

Market Cap
308m USD
Industry
Food Products

Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.

LFCR Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1.8%
=
Operating Income
$-2.4m
/
Revenue
$135.3m
What is Lifecore Biomedical Inc's current Operating Margin?

The current Operating Margin for Lifecore Biomedical Inc is -1.8%, which is above its 3-year median of -11.5%.

How has Operating Margin changed over time?

Over the last 3 years, Lifecore Biomedical Inc’s Operating Margin has increased from -17.7% to -1.8%. During this period, it reached a low of -25.7% on Aug 27, 2023 and a high of -1.8% on Oct 30, 2025.

Back to Top